MEDS (DataMEDS AI) Pretax Margin %: -496.35% (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is DataMEDS AI Pretax Margin %?

DataMEDS AI MEDS -3.35% Pretax Margin % is -496.35% as of Mar. 2026. The stock has 6 warning signs investors should review. Among 119 Medical Distribution companies, DataMEDS AI ranks worse than 99.16% on this metric.

Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. DataMEDS AI's Pre-Tax Income for the three months ended in Mar. 2026 was $-7.74 Mil. DataMEDS AI's Revenue for the three months ended in Mar. 2026 was $1.56 Mil. Therefore, DataMEDS AI's pretax margin for the quarter that ended in Mar. 2026 was -496.35%.

The historical rank and industry rank for DataMEDS AI's Pretax Margin % or its related term are showing as below:

MEDS' s Pretax Margin % Range Over the Past 10 Years
Min: -545.68   Med: -37.82   Max: -8.37
Current: -545.68


MEDS's Pretax Margin % is ranked worse than
99.16% of 119 companies
in the Medical Distribution industry
Industry Median: 2.18 vs MEDS: -545.68

DataMEDS AI  (NAS:MEDS) Pretax Margin % Explanation

The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.

The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.

It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.

The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.


DataMEDS AI Pretax Margin % Related Terms


DataMEDS AI Pretax Margin % Historical Data

* Premium members only.

The historical data trend for DataMEDS AI's Pretax Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

DataMEDS AI Pretax Margin % Chart

DataMEDS AI Annual Data
Trend Dec22 Dec23 Dec24 Dec25
Pretax Margin %
-8.37 0.00 -37.82 -433.95

DataMEDS AI Quarterly Data
Dec22 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Pretax Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only -298.55 -85.64 -1,139.00 -1,666.85 -496.35

MEDS vs HEWA, BLMH, PMHS: Pretax Margin % Comparison

For the Medical Distribution subindustry, DataMEDS AI's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


DataMEDS AI Pretax Margin % vs Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, DataMEDS AI's Pretax Margin % distribution charts can be found below:

* The bar in red indicates where DataMEDS AI's Pretax Margin % falls into.



DataMEDS AI Pretax Margin % Calculation

Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.

DataMEDS AI's Pretax Margin for the fiscal year that ended in Dec. 2025 is calculated as

Pretax Margin=Pre-Tax Income (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-101.275/23.338
=-433.95 %

DataMEDS AI's Pretax Margin for the quarter that ended in Mar. 2026 is calculated as

Pretax Margin=Pre-Tax Income (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=-7.743/1.56
=-496.35 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Pretax Margin % →
What does a Pretax Margin % of -496.35% mean?
DataMEDS AI (MEDS) has a Pretax Margin % of -496.35% as of Mar. 2026. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on DataMEDS AI and its competitors. According to the industry distribution chart, DataMEDS AI ranks #118 out of 119 companies in the Medical Distribution industry, placing it in the top 99.2%.
Is DataMEDS AI's Pretax Margin % too high?
DataMEDS AI's current Pretax Margin % is -496.35%. Based on the distribution chart, DataMEDS AI ranks #118 out of 119 companies in the Medical Distribution industry, which is in the bottom quartile relative to peers.
How does DataMEDS AI's Pretax Margin % compare to HEWA and BLMH?
According to the Medical Distribution industry distribution chart, DataMEDS AI ranks #118 out of 119 companies for Pretax Margin %. This places DataMEDS AI in the lower half of its industry. The industry median Pretax Margin % is 2.18. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pretax Margin % for a Medical Distribution company?
The median Pretax Margin % among Medical Distribution companies is 2.18, based on 119 companies in the industry. Companies in the top quartile (top 25%) have a Pretax Margin % significantly above this median, while those in the bottom quartile fall well below. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pretax Margin % mean?
A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on DataMEDS AI and its competitors. For the Medical Distribution industry, the median Pretax Margin % is 2.18 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. DataMEDS AI's current Pretax Margin % is -496.35%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is DataMEDS AI stock overvalued right now?
DataMEDS AI (MEDS) has a current Pretax Margin % of -496.35%. The current Pretax Margin % is -496.35%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pretax Margin % calculated?
Pretax Margin % is calculated from a company's financial statements. For DataMEDS AI (MEDS), the current Pretax Margin % is -496.35% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

DataMEDS AI Business Description

Address 3000 Bayport Drive, Suite 950, Tampa, FL, USA, 33607
Wellgistics Health Inc is a healthcare technology and pharmaceutical logistics company. It simplifies the logistics of prescription fulfillment from the manufacturer and provider to the patient. The company seeks to be a micro health ecosystem, with a portfolio comprising a pharmacy, wholesale operations, and a technology division that provides a novel platform for hub and clinical services. It is focused on improving the lives of patients while delivering solutions for pharmacies, providers, pharmaceutical manufacturers, and payors.